BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot M, Hop WC, Schalm SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-9. [DOI: 10.1002/hep.510280108] [Cited by in Crossref: 363] [Cited by in F6Publishing: 327] [Article Influence: 15.1] [Reference Citation Analysis]
Number Citing Articles
1 Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768-773. [PMID: 11434627 DOI: 10.1016/s0168-8278(01)00026-5] [Cited by in Crossref: 491] [Cited by in F6Publishing: 194] [Article Influence: 23.4] [Reference Citation Analysis]
2 Liu JY, Ding J, Lin D, He YF, Dai Z, Chen CZ, Cheng WZ, Wang H, Zhou J, Wang X. T2* MRI of minimal hepatic encephalopathy and cognitive correlates in vivo. J Magn Reson Imaging. 2013;37:179-186. [PMID: 23011760 DOI: 10.1002/jmri.23811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
3 Córdoba J, Flavià M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardia J. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol. 2003;39:231-238. [PMID: 12873820 DOI: 10.1016/s0168-8278(03)00189-2] [Cited by in Crossref: 146] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
4 Hashemi F, Fathi Ashtiani A, Mirminachi B, Sharafkhah M, Ekhlasi G, Jafari E, Poustchi H. Impact of Hepatitis C Virus Infection on Cognitive Function in Patients With Covert Hepatic Encephalopathy. Hepat Mon. 2015;15:e30507. [PMID: 26300936 DOI: 10.5812/hepatmon.30507v2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Zafiris O, Kircheis G, Rood HA, Boers F, Häussinger D, Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study.Neuroimage. 2004;22:541-552. [PMID: 15193582 DOI: 10.1016/j.neuroimage.2004.01.038] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
6 Liu C, Wang L, Xu M, Sun Y, Xing Z, Zhang J, Wang C, Dong L. Reprogramming the spleen into a functioning 'liver' in vivo. Gut 2022:gutjnl-2021-325018. [PMID: 34996824 DOI: 10.1136/gutjnl-2021-325018] [Reference Citation Analysis]
7 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
8 Romero-gómez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology 2004;39:939-43. [DOI: 10.1002/hep.20152] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
9 Apelqvist G, Wikell C, Carlsson B, Hjorth S, Bergqvist PB, Ahlner J, Bengtsson F. Dynamic and Kinetic Effects of Chronic Citalopram Treatment in Experimental Hepatic Encephalopathy: . Clinical Neuropharmacology 2000;23:304-17. [DOI: 10.1097/00002826-200011000-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
10 Sunmonu TA, Adekanle O, Komolafe MA, Ndububa DA. Cognitive function in patients with liver cirrhosis without overt hepatic encephalopathy: assessment using an automated neuropsychological test battery. Arab J Gastroenterol 2012;13:4-8. [PMID: 22560817 DOI: 10.1016/j.ajg.2012.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Häussinger D, Córdoba J, Kircheis G, Vilstrup H, Fleig WE, Jones EA, Schleiss F, Blei AT. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 423-32. [DOI: 10.1007/1-4020-4456-9_32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol. 2007;102:754-760. [PMID: 17222319 DOI: 10.1111/j.1572-0241.2007.01048.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 7.2] [Reference Citation Analysis]
13 Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol. 2010;16:181-187. [PMID: 20616413 DOI: 10.4103/1319-3767.65189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
14 Heidari R, Jamshidzadeh A, Ommati MM, Rashidi E, Khodaei F, Sadeghi A, Hosseini A, Niknahad H. Ammonia-induced mitochondrial impairment is intensified by manganese co-exposure: relevance to the management of subclinical hepatic encephalopathy and cirrhosis-associated brain injury. Clin Exp Hepatol 2019;5:109-17. [PMID: 31501786 DOI: 10.5114/ceh.2019.85071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Lauridsen MM, Poulsen L, Rasmussen CK, Høgild M, Nielsen M, de Muckadell OBS, Vilstrup H. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy. Metab Brain Dis 2016;31:267-72. [DOI: 10.1007/s11011-015-9741-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
16 Kugelberg FC, Apelqvist G, Carlsson B, Ahlner J, Bengtsson F. Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatonin. Basic Clin Pharmacol Toxicol 2006;99:80-8. [PMID: 16867175 DOI: 10.1111/j.1742-7843.2006.pto_449.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
17 Arias N, Méndez M, Fidalgo C, Aller MÁ, Arias J, Arias JL. Mapping metabolic brain activity in three models of hepatic encephalopathy. Int J Hypertens 2013;2013:390872. [PMID: 23573412 DOI: 10.1155/2013/390872] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
18 ter Borg PCJ, Hollemans M, van Buuren HR, Vleggaar FP, Groeneweg M, Hop WCJ, Laméris JS. Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3–9 Years. Radiology 2004;231:537-45. [DOI: 10.1148/radiol.2312021797] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wunsch E, Szymanik B, Post M, Marlicz W, Mydłowska M, Milkiewicz P. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study. Liver Int 2011;31:980-4. [PMID: 21733087 DOI: 10.1111/j.1478-3231.2011.02465.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
20 Greinert R, Ripoll C, Zipprich A. Covert hepatic encephalopathy leads to distinct alterations in the emotional state, independently of MELD-Score. Z Gastroenterol 2018;56:461-8. [PMID: 29341039 DOI: 10.1055/s-0043-123766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. Am J Gastroenterol. 2007;102:744-753. [PMID: 17222324 DOI: 10.1111/j.1572-0241.2006.01028.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
22 Kosenko EA, Tikhonova LA, Alilova GA, Montoliu C, Barreto GE, Aliev G, Kaminsky YG. Portacaval shunting causes differential mitochondrial superoxide production in brain regions. Free Radical Biology and Medicine 2017;113:109-18. [DOI: 10.1016/j.freeradbiomed.2017.09.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
23 Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007;47:642-50. [PMID: 17869373 DOI: 10.1016/j.jhep.2007.05.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
24 Chen HJ, Jiang LF, Sun T, Liu J, Chen QF, Shi HB. Resting-state functional connectivity abnormalities correlate with psychometric hepatic encephalopathy score in cirrhosis. Eur J Radiol 2015;84:2287-95. [PMID: 26321490 DOI: 10.1016/j.ejrad.2015.08.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
25 Teodoro V, Bragagnolo Jr. M, Lucchesi L, Kondo M, Tufik S. Avaliação dos potenciais evocados relacionados a eventos (ERP-P300) em pacientes com cirrose hepática sem encefalopatia. Arq Gastroenterol 2008;45:82-6. [DOI: 10.1590/s0004-28032008000100015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Lauridsen MM, Schaffalitzky de Muckadell OB, Vilstrup H. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests. Metab Brain Dis. 2015;30:1187-1192. [PMID: 26016624 DOI: 10.1007/s11011-015-9688-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
27 Kawaguchi T, Konishi M, Kato A, Kato M, Kooka Y, Sawara K, Endo R, Torimura T, Suzuki K, Takikawa Y. Updating the neuropsychological test system in Japan for the elderly and in a modern touch screen tablet society by resetting the cut-off values. Hepatol Res. 2017;47:1335-1339. [PMID: 28066966 DOI: 10.1111/hepr.12864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
28 Prakash RK, Kanna S, Mullen KD. Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis. Clinical Therapeutics 2013;35:1458-73. [DOI: 10.1016/j.clinthera.2013.07.421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
29 Román E, Córdoba J, Torrens M, Guarner C, Soriano G. Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis. Eur J Gastroenterol Hepatol 2013;25:77-84. [PMID: 22954704 DOI: 10.1097/MEG.0b013e3283589f49] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
30 Guérit JM, Amodio P, Hafner H, Litscher G, Van Huffelen AC. Neuromonitoring in the operating room and intensive care unit: an update. Suppl Clin Neurophysiol 2000;53:61-71. [PMID: 12740978 DOI: 10.1016/s1567-424x(09)70139-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Atluri DK, Prakash R, Mullen KD. Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J Clin Exp Hepatol. 2011;1:77-86. [PMID: 25755319 DOI: 10.1016/s0973-6883(11)60126-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
32 Ong JP, Mullen KD. Hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2001;13:325-334. [PMID: 11338058 DOI: 10.1097/00042737-200104000-00005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
33 Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther. 2011;33:662-671. [PMID: 21251030 DOI: 10.1111/j.1365-2036.2010.04574.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 102] [Article Influence: 11.1] [Reference Citation Analysis]
34 Vasudevan AE, Goh KL, Bulgiba AM. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol. 2002;97:1717-1721. [PMID: 12135024 DOI: 10.1111/j.1572-0241.2002.05831.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
35 Nikaina I, Pastaka C, Zachou K, Dalekos GN, Gourgoulianis K. Sleep apnoea syndrome and early stage cirrhosis: a pilot study. Eur J Gastroenterol Hepatol 2006;18:31-5. [PMID: 16357616 DOI: 10.1097/00042737-200601000-00006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
36 Bragagnolo Jr. MA, Teodoro V, Lucchesi LM, Ribeiro TCDR, Tufik S, Kondo M. Detecção de encefalopatia hepática mínima através de testes neuropsicológicos e neurofisiológicos e o papel da amônia no seu diagnóstico. Arq Gastroenterol 2009;46:43-9. [DOI: 10.1590/s0004-28032009000100013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic encephalopathy. Arch Biochem Biophys. 2013;536:189-196. [PMID: 23583306 DOI: 10.1016/j.abb.2013.03.016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
38 Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J, Pleuss JA, Krakower G, Hoffmann RG, Binion DG. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707-1715. [PMID: 18691193 DOI: 10.1111/j.1572-0241.2008.01861.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 13.0] [Reference Citation Analysis]
39 Lockwood AH. Hepatic Encephalopathy. Neurologic Clinics 2002;20:241-6. [DOI: 10.1016/s0733-8619(03)00061-6] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
40 Kimbell B, Murray SA. What is the patient experience in advanced liver disease? A scoping review of the literature. BMJ Support Palliat Care 2015;5:471-80. [DOI: 10.1136/bmjspcare-2012-000435] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
41 Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis. Arab J Gastroenterol. 2011;12:58-61. [PMID: 21684474 DOI: 10.1016/j.ajg.2011.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
42 Hassanein TI, Hilsabeck RC, Perry W. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig Dis Sci. 2008;53:529-538. [PMID: 17710551 DOI: 10.1007/s10620-007-9895-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
43 Roggeri DP, Roggeri A. Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy. Hepat Med 2017;9:37-43. [PMID: 29026340 DOI: 10.2147/HMER.S146438] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
44 García-García R, Cruz-Gómez ÁJ, Mangas-Losada A, Urios A, Forn C, Escudero-García D, Kosenko E, Ordoño JF, Tosca J, Giner-Durán R, Serra MA, Avila C, Belloch V, Felipo V, Montoliu C. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy. PLoS One 2017;12:e0186463. [PMID: 29023586 DOI: 10.1371/journal.pone.0186463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
45 Douglass A, Al Mardini H, Record CO. Oral tryptophan challenge studies in cirrhotic patients: no evidence of neuropsychiatric changes. Metab Brain Dis 2003;18:179-86. [PMID: 14567468 DOI: 10.1023/a:1025577614928] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, Urios A, Mestre-Salvador V, Correa-Ghisays P, Ballester MP, Escudero-García D, Tosca J, Montón C, Ríos MP, Kosenko E, Felipo V, Tabares-Seisdedos R, Selva-Vera G, Montoliu C. Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy. J Clin Med 2020;9:E2154. [PMID: 32650464 DOI: 10.3390/jcm9072154] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55:2381-2390. [PMID: 20508990 DOI: 10.1007/s10620-010-1249-7] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 10.7] [Reference Citation Analysis]
48 Qi R, Zhang LJ, Luo S, Ke J, Kong X, Xu Q, Liu C, Lu H, Lu GM. Default mode network functional connectivity: a promising biomarker for diagnosing minimal hepatic encephalopathy: CONSORT-compliant article. Medicine (Baltimore) 2014;93:e227. [PMID: 25501083 DOI: 10.1097/MD.0000000000000227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
49 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int. 2009;29:1365-1371. [PMID: 19555401 DOI: 10.1111/j.1478-3231.2009.02067.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
50 Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol. 2012;10:1208-1219. [PMID: 22728384 DOI: 10.1016/j.cgh.2012.05.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
51 Chen HJ, Jiao Y, Zhu XQ, Zhang HY, Liu JC, Wen S, Teng GJ. Brain dysfunction primarily related to previous overt hepatic encephalopathy compared with minimal hepatic encephalopathy: resting-state functional MR imaging demonstration.Radiology. 2013;266:261-270. [PMID: 23047839 DOI: 10.1148/radiol.12120026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
52 Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, Guardia J, Córdoba J. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol. 2010;22:221-227. [PMID: 19794311 DOI: 10.1097/meg.0b013e3283319975] [Cited by in Crossref: 95] [Cited by in F6Publishing: 45] [Article Influence: 7.9] [Reference Citation Analysis]
53 Lin D, Ding J, Liu JY, He YF, Dai Z, Chen CZ, Cheng WZ, Zhou J, Wang X. Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis. PLoS One 2013;8:e65551. [PMID: 23776499 DOI: 10.1371/journal.pone.0065551] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
54 Mullen KD, Prakash RK. Management of covert hepatic encephalopathy. Clin Liver Dis. 2012;16:91-93. [PMID: 22321467 DOI: 10.1016/j.cld.2011.12.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
55 Felipo V, Urios A, Valero P, Sánchez M, Serra MA, Pareja I, Rodríguez F, Gimenez-Garzó C, Sanmartín J, Montoliu C. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy. Liver Int. 2013;33:1478-1489. [PMID: 23714168 DOI: 10.1111/liv.12206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
56 Stinton LM, Jayakumar S. Minimal hepatic encephalopathy. Can J Gastroenterol 2013;27:572-4. [PMID: 24106728 DOI: 10.1155/2013/547670] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
57 Blei AT, Córdoba J. Hepatic Encephalopathy. Am J Gastroenterol. 2001;96:1968-1976. [PMID: 11467622 DOI: 10.1111/j.1572-0241.2001.03964.x] [Cited by in Crossref: 421] [Cited by in F6Publishing: 359] [Article Influence: 20.0] [Reference Citation Analysis]
58 Greinert R, Ripoll C, Hollenbach M, Zipprich A. Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach. Aliment Pharmacol Ther 2016;44:514-21. [PMID: 27385440 DOI: 10.1111/apt.13721] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
59 Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM, Felipo V. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med (Berl). 2007;85:237-245. [PMID: 17216205 DOI: 10.1007/s00109-006-0149-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
60 Qi R, Zhang LJ, Zhong J, Zhang Z, Ni L, Zheng G, Lu GM. Disrupted thalamic resting-state functional connectivity in patients with minimal hepatic encephalopathy. Eur J Radiol. 2013;82:850-856. [PMID: 23332976 DOI: 10.1016/j.ejrad.2012.12.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
61 Moscucci F, Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Merli M, Riggio O. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int 2011;31:1505-10. [PMID: 22093325 DOI: 10.1111/j.1478-3231.2011.02598.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
62 Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22:125-138. [PMID: 17260161 DOI: 10.1007/s11011-006-9042-1] [Cited by in Crossref: 160] [Cited by in F6Publishing: 149] [Article Influence: 10.7] [Reference Citation Analysis]
63 Lauridsen MM, Jepsen P, Wernberg CW, Schaffalitzky de Muckadell OB, Bajaj JS, Vilstrup H. Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy. Hepatol Commun 2020;4:1353-61. [PMID: 32923838 DOI: 10.1002/hep4.1555] [Reference Citation Analysis]
64 De Silva AP, Niriella MA, Ediriweera DS, De Alwis JP, Liyanage IK, Ettickan U, Liyanapathirana KV, Undugodage C, de Silva HA, de Silva HJ. Low-dose melatonin for sleep disturbances in early-stage cirrhosis: A randomized, placebo-controlled, cross-over trial. JGH Open 2020;4:749-56. [PMID: 32782966 DOI: 10.1002/jgh3.12356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Ferenci P, Müller C. Hepatic Encephalopathy: Treatment. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 636-49. [DOI: 10.1002/9781444314403.ch39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Ciećko-Michalska I, Szczepanek M, Słowik A, Mach T. Pathogenesis of hepatic encephalopathy. Gastroenterol Res Pract 2012;2012:642108. [PMID: 23316223 DOI: 10.1155/2012/642108] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
67 Stokes CS, Goh ET, Vilstrup H, Morgan MY, Gluud LL; Cochrane Hepato-Biliary Group. L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012410] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol. 2000;32:748-753. [PMID: 10845661 DOI: 10.1016/s0168-8278(00)80243-3] [Cited by in Crossref: 127] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
69 Zullo A, Hassan C, Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol. 2003;37:164-168. [PMID: 12869889 DOI: 10.1097/00004836-200308000-00014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
70 Ghiassy B, Rahimi N, Javadi-Paydar M, Gharedaghi MH, Norouzi-Javidan A, Dehpour AR. Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats. Can J Physiol Pharmacol 2017;95:16-22. [PMID: 28044452 DOI: 10.1139/cjpp-2016-0188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
71 Montgomery JY, Bajaj JS. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep. 2011;13:26-33. [PMID: 20924726 DOI: 10.1007/s11894-010-0150-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
72 Zacharias HD, Zacharias AP, Gluud LL, Morgan MY. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Cochrane Database Syst Rev 2019;6:CD012334. [PMID: 31204790 DOI: 10.1002/14651858.CD012334.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
73 Olesen SS, Gram M, Jackson CD, Halliday E, Sandberg TH, Drewes AM, Morgan MY. Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy. J Hepatol 2016;65:517-23. [PMID: 27184531 DOI: 10.1016/j.jhep.2016.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
74 Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16. [PMID: 19529896 DOI: 10.1007/s12664-009-0003-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
75 Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, de Madaria E, Montoliu C, Nuñez D, Flavia M, Compañy L, Rodrigo JM, Felipo V. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879-85. [PMID: 17393525 DOI: 10.1002/hep.21586] [Cited by in Crossref: 212] [Cited by in F6Publishing: 183] [Article Influence: 14.1] [Reference Citation Analysis]
76 Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, Gibson DP, Hoffmann RG, Stravitz RT, Heuman DM, Sterling RK, Shiffman M, Topaz A, Boyett S, Bell D, Sanyal AJ. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50:1175-1183. [PMID: 19670416 DOI: 10.1002/hep.23128] [Cited by in Crossref: 210] [Cited by in F6Publishing: 178] [Article Influence: 16.2] [Reference Citation Analysis]
77 Bajaj JS. Diagnosing minimal hepatic encephalopathy: from the ivory tower to the real world. Gastroenterology 2015;149:1330-3. [PMID: 26416330 DOI: 10.1053/j.gastro.2015.09.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
78 Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: From diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151-164. [PMID: 29507462 DOI: 10.20524/aog.2018.0232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
79 Romero-Gómez M. Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy. J Hepatol. 2007;47:10-11. [PMID: 17507110 DOI: 10.1016/j.jhep.2007.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
80 Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67-73. [PMID: 17459511 DOI: 10.1016/j.jhep.2007.02.022] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 8.2] [Reference Citation Analysis]
81 Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver. 2002;22:190-197. [PMID: 12100568 DOI: 10.1034/j.1600-0676.2002.01431.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
82 Schulz C, Schütte K, Kropf S, Schmitt FC, Vasapolli R, Kliegis LM, Riegger A, Malfertheiner P. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial. Trials. 2016;17:111. [PMID: 26926775 DOI: 10.1186/s13063-016-1205-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
83 Savlan I, Liakina V, Valantinas J. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy. Medicina (Kaunas). 2014;50:75-81. [PMID: 25172600 DOI: 10.1016/j.medici.2014.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
84 Huang E, Esrailian E, Spiegel BM. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis. Aliment Pharmacol Ther. 2007;26:1147-1161. [PMID: 17894657 DOI: 10.1111/j.1365-2036.2007.03464.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
85 Wang JY, Zhang NP, Chi BR, Mi YQ, Meng LN, Liu YD, Wang JB, Jiang HX, Yang JH, Xu Y, Li X, Xu JM, Zhang G, Zhou XM, Zhuge YZ, Tian DA, Ye J, Liu YL. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol 2013; 19(30): 4984-4991 [PMID: 23946605 DOI: 10.3748/wjg.v19.i30.4984] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
86 Zhan T, Stremmel W. The diagnosis and treatment of minimal hepatic encephalopathy. Dtsch Arztebl Int. 2012;109:180-187. [PMID: 22470407 DOI: 10.3238/arztebl.2012.0180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
87 Qi R, Zhang LJ, Chen HJ, Zhong J, Luo S, Ke J, Xu Q, Kong X, Liu C, Lu GM. Role of local and distant functional connectivity density in the development of minimal hepatic encephalopathy. Sci Rep 2015;5:13720. [PMID: 26329994 DOI: 10.1038/srep13720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
88 Grønkjær LL, Lauridsen MM. Impact of liver disease on patients' quality of life: a mixed methods systematic review protocol. JBI Evid Synth 2020;19:1412-7. [PMID: 33323778 DOI: 10.11124/JBIES-20-00185] [Reference Citation Analysis]
89 Olesen SS, Jackson CD, Gram M, Zacharias HD, Dirks M, Weissenborn K, Drewes AM, Morgan MY. Cortical networks are disturbed in people with cirrhosis even in the absence of neuropsychometric impairment. Clin Neurophysiol 2019;130:419-27. [PMID: 30552046 DOI: 10.1016/j.clinph.2018.11.011] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
90 Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients. Aliment Pharmacol Ther. 2018;48:313-321. [PMID: 29863286 DOI: 10.1111/apt.14824] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
91 Chen HJ, Zhu XQ, Jiao Y, Li PC, Wang Y, Teng GJ. Abnormal baseline brain activity in low-grade hepatic encephalopathy: a resting-state fMRI study. J Neurol Sci. 2012;318:140-145. [PMID: 22541365 DOI: 10.1016/j.jns.2012.02.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
92 Leke R, de Oliveira DL, Mussulini BH, Pereira MS, Kazlauckas V, Mazzini G, Hartmann CR, Silveira TR, Simonsen M, Bak LK, Waagepetersen HS, Keiding S, Schousboe A, Portela LV. Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats. PLoS One 2012;7:e36322. [PMID: 22586467 DOI: 10.1371/journal.pone.0036322] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
93 Kalaitzakis E, Björnsson E. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life. Hepatology. 2007;46:949-50; author reply 951. [PMID: 17879365 DOI: 10.1002/hep.21760] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
94 Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL, Morgan MY. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2018;5:CD012410. [PMID: 29762873 DOI: 10.1002/14651858.cd012410.pub2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
95 Allampati SK, Mullen KD. Understanding the impact of neurologic complications in patients with cirrhosis. SAGE Open Med. 2019;7:2050312119832090. [PMID: 30834114 DOI: 10.1177/2050312119832090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Ladegaard Grønkjær L, Hoppe Sehstedt T, Norlyk A, Vilstrup H. Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study. Gastroenterol Nurs 2018;41:468-76. [PMID: 28759517 DOI: 10.1097/SGA.0000000000000286] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
97 Schmid M, Mittermaier C, Voller B, Fialka-moser V, Gangl A, Peck-radosavljevic M. Postural control in patients with liver cirrhosis: a posturographic study: . European Journal of Gastroenterology & Hepatology 2009;21:915-22. [DOI: 10.1097/meg.0b013e328321b0fd] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Poh Z, Chang PE. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol. 2012;2012:480309. [PMID: 23133760 DOI: 10.1155/2012/480309] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
99 Jover R, Compañy L, Gutiérrez A, Zapater P, Pérez-serra J, Girona E, Aparicio JR, Pérez-mateo M. Minimal Hepatic Encephalopathy and Extrapyramidal Signs in Patients With Cirrhosis. American Journal of Gastroenterology 2003;98:1599-604. [DOI: 10.1111/j.1572-0241.2003.07528.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
100 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;CD003044. [PMID: 27153247 DOI: 10.1002/14651858.cd003044.pub4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
101 Giménez-Garzó C, Garcés JJ, Urios A, Mangas-Losada A, García-García R, González-López O, Giner-Durán R, Escudero-García D, Serra MA, Soria E, Felipo V, Montoliu C. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. PLoS One 2017;12:e0171211. [PMID: 28146589 DOI: 10.1371/journal.pone.0171211] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
102 Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M. Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs. Hepat Med. 2015;7:37-42. [PMID: 26203290 DOI: 10.2147/hmer.s87594] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
103 Amodio P. Health related quality of life and minimal hepatic encephalopathy. It is time to insert ‘quality’ in health care. Journal of Gastroenterology and Hepatology 2009;24:329-30. [DOI: 10.1111/j.1440-1746.2009.05781.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
104 Grover VP, Crossey MM, Fitzpatrick JA, Saxby BK, Shaw R, Waldman AD, Morgan MY, Taylor-Robinson SD. Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study. Metab Brain Dis 2016;31:1315-25. [PMID: 26251205 DOI: 10.1007/s11011-015-9716-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
105 Nabi E, Bajaj JS. Useful tests for hepatic encephalopathy in clinical practice. Curr Gastroenterol Rep. 2014;16:362. [PMID: 24357348 DOI: 10.1007/s11894-013-0362-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
106 Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, Jones DE. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61:1158-1165. [PMID: 25010259 DOI: 10.1016/j.jhep.2014.06.034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 8.5] [Reference Citation Analysis]
107 Jiang SF, Shi JY, Yang ZT, Zhang L, Chen HJ. Aberrant dynamic functional network connectivity in cirrhotic patients without overt hepatic encephalopathy.Eur J Radiol. 2020;132:109324. [PMID: 33038576 DOI: 10.1016/j.ejrad.2020.109324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
108 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;7:CD002798. [PMID: 28745801 DOI: 10.1002/14651858.CD002798.pub3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
109 Dávalos Moscol M, Bustios Sanchez C. The burden of hepatic encephalopathy in Latin America. Annals of Hepatology 2011;10:S31-5. [DOI: 10.1016/s1665-2681(19)31603-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
110 Qi R, Zhang LJ, Zhong J, Zhu T, Zhang Z, Xu C, Zheng G, Lu GM. Grey and white matter abnormalities in minimal hepatic encephalopathy: a study combining voxel-based morphometry and tract-based spatial statistics. Eur Radiol. 2013;23:3370-3378. [PMID: 23839169 DOI: 10.1007/s00330-013-2963-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
111 Vergara-Gómez M, Flavià-Olivella M, Gil-Prades M, Dalmau-Obrador B, Córdoba-Cardona J. [Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists]. Gastroenterol Hepatol 2006;29:1-6. [PMID: 16393622 DOI: 10.1157/13083245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
112 Yamamoto M, Iwasa M, Matsumura K, Nakagawa Y, Fujita N, Kobayashi Y, Kaito M, Takeda K, Adachi Y. Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol 2005; 11(43): 6792-6799 [PMID: 16425386 DOI: 10.3748/wjg.v11.i43.6792] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
113 Stewart CA, Smith GE. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol. 2007;4:677-685. [PMID: 18043677 DOI: 10.1038/ncpgasthep0999] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
114 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;8:CD002798. [PMID: 28796283 DOI: 10.1002/14651858.CD002798.pub4] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
115 Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol. 2001;16:531-535. [PMID: 11350549 DOI: 10.1046/j.1440-1746.2001.02487.x] [Cited by in Crossref: 207] [Cited by in F6Publishing: 186] [Article Influence: 9.9] [Reference Citation Analysis]
116 Mechtcheriakov S, Graziadei IW, Mattedi M, Bodner T, Kugener A, Hinterhuber HH, Marksteiner J, Vogel W. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl. 2004;10:77-83. [PMID: 14755782 DOI: 10.1002/lt.20009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
117 Yadav SK, Saksena S, Srivastava A, Srivastava A, Saraswat VA, Thomas MA, Rathore RK, Gupta RK. Brain MR imaging and 1H-MR spectroscopy changes in patients with extrahepatic portal vein obstruction from early childhood to adulthood. AJNR Am J Neuroradiol 2010;31:1337-42. [PMID: 20223885 DOI: 10.3174/ajnr.A2045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
118 Chen HJ, Lin HL, Chen QF, Liu PF. Altered dynamic functional connectivity in the default mode network in patients with cirrhosis and minimal hepatic encephalopathy. Neuroradiology 2017;59:905-14. [PMID: 28707166 DOI: 10.1007/s00234-017-1881-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
119 Chen HJ, Zhang L, Jiang LF, Chen QF, Li J, Shi HB. Identifying minimal hepatic encephalopathy in cirrhotic patients by measuring spontaneous brain activity.Metab Brain Dis. 2016;31:761-769. [PMID: 26886109 DOI: 10.1007/s11011-016-9799-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
120 Tivers MS, Handel I, Gow AG, Lipscomb VJ, Jalan R, Mellanby RJ. Attenuation of congenital portosystemic shunt reduces inflammation in dogs. PLoS One 2015;10:e0117557. [PMID: 25658922 DOI: 10.1371/journal.pone.0117557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
121 Strebel H, Haller B, Sohn M, Schepp W, Gundling F. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE Port J Gastroenterol 2020;27:391-403. [PMID: 33251288 DOI: 10.1159/000507225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Chen HJ, Chen QF, Liu J, Shi HB. Aberrant salience network and its functional coupling with default and executive networks in minimal hepatic encephalopathy: a resting-state fMRI study. Sci Rep. 2016;6:27092. [PMID: 27250065 DOI: 10.1038/srep27092] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
123 Gençdal G, Türker G, Yazıcı Gençdal I, Ekinci B, Acar Ş, Dinçkan A, Akyıldız M. Assessment of sleep pattern and quality before and after liver transplantation using different methods. Turk J Gastroenterol 2020;31:581-7. [PMID: 32915146 DOI: 10.5152/tjg.2020.18809] [Reference Citation Analysis]
124 Mittal VV, Sharma BC, Sharma P, Sarin SK. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2011;23:725-732. [PMID: 21646910 DOI: 10.1097/meg.0b013e32834696f5] [Cited by in Crossref: 118] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
125 Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-45. [DOI: 10.1002/hep.20095] [Cited by in Crossref: 215] [Cited by in F6Publishing: 181] [Article Influence: 11.9] [Reference Citation Analysis]
126 Córdoba J. Quality of life in chronic liver diseases and in hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 442-57. [DOI: 10.1007/1-4020-4456-9_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Cai X, Wang L, Hu C. Retracted : Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta‐analysis involving 826 patients based on 10 randomized controlled trials. J Cell Biochem 2018;119:8336-45. [DOI: 10.1002/jcb.26886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
128 Blei AT. Diagnosis and treatment of hepatic encephalopathy. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:959-974. [PMID: 11139349 DOI: 10.1053/bega.2000.0141] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
129 Lockwood AH. "What's in a name?" Improving the care of cirrhotics. J Hepatol. 2000;32:859-861. [PMID: 10845675 DOI: 10.1016/s0168-8278(00)80257-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
130 Taneja S, Dhiman RK. Can Testing the Impact of Minimal Hepatic Encephalopathy on Driving Skills be Prolific to Translate Research to Real Life Clinical Medicine? J Clin Exp Hepatol 2016;6:1-2. [PMID: 27194888 DOI: 10.1016/j.jceh.2016.03.007] [Reference Citation Analysis]
131 Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres ML, Civera M, Olmo JA, Ortega J, Martinez-Valls J, Serra MA. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis. 2012;27:51-58. [PMID: 22072427 DOI: 10.1007/s11011-011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology. 2008;47:596-604. [PMID: 18000989 DOI: 10.1002/hep.22032] [Cited by in Crossref: 113] [Cited by in F6Publishing: 96] [Article Influence: 8.1] [Reference Citation Analysis]
133 Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, Montagnese S, Schiff S, Weissenborn K. Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis 2016;31:1217-29. [PMID: 26412229 DOI: 10.1007/s11011-015-9726-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
134 Pascoli D, Guérit J, Montagnese S, de Tourtchaninoff M, Minelli T, Pellegrini A, Del Piccolo F, Gatta A, Amodio P. Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy. Computer Methods and Programs in Biomedicine 2006;81:203-12. [DOI: 10.1016/j.cmpb.2005.10.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
135 Córdoba J, Lucke R. Driving under the influence of minimal hepatic encephalopathy. Hepatology 2004;39:599-601. [DOI: 10.1002/hep.20120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
136 Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35:357-366. [PMID: 11826409 DOI: 10.1053/jhep.2002.30957] [Cited by in Crossref: 279] [Cited by in F6Publishing: 234] [Article Influence: 14.0] [Reference Citation Analysis]
137 Soárez PCD, Oliveira AC, Padovan J, Parise ER, Ferraz MB. A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment. Arq Gastroenterol 2009;46:241-7. [DOI: 10.1590/s0004-28032009000300019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
138 Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95:2029-2034. [PMID: 10950053 DOI: 10.1111/j.1572-0241.2000.02265.x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 134] [Article Influence: 6.7] [Reference Citation Analysis]
139 Romero-Gómez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002;37:781-7. [PMID: 12445419 DOI: 10.1016/s0168-8278(02)00330-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
140 D’antiga L, Dacchille P, Boniver C, Poledri S, Schiff S, Zancan L, Amodio P. Clues for Minimal Hepatic Encephalopathy in Children With Noncirrhotic Portal Hypertension. Journal of Pediatric Gastroenterology & Nutrition 2014;59:689-94. [DOI: 10.1097/mpg.0000000000000537] [Cited by in Crossref: 14] [Article Influence: 1.8] [Reference Citation Analysis]
141 Bamidele OF, Olokoba AB, Bojuwoye MO, Akintayo RO, Bamidele O. Prevalence of minimal hepatic encephalopathy among patients with chronic liver disease in Ilorin, Nigeria. Ghana Med J 2019;53:299-303. [PMID: 32116342 DOI: 10.4314/gmj.v53i4.8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
142 Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, Fuchs M, Bouneva I, Puri P, Luketic V, Sanyal AJ, Gilles H, Heuman DM, Bajaj JS. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol. 2013;59:467-473. [PMID: 23665182 DOI: 10.1016/j.jhep.2013.04.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
143 Munk Lauridsen M, Vilstrup H. Diagnosing covert hepatic encephalopathy. Clin Liver Dis (Hoboken) 2015;5:71-4. [PMID: 31040954 DOI: 10.1002/cld.451] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
144 Paulson D, Shah M, Miller-Matero LR, Eshelman A, Abouljoud M. Cognition Predicts Quality of Life Among Patients With End-Stage Liver Disease. Psychosomatics 2016;57:514-21. [PMID: 27184728 DOI: 10.1016/j.psym.2016.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
145 Teodoro VV, Júnior MAB, Lucchesi LM, Cavignolli D, Mello MT, Kondo M, Tufik S. Polysomnographic sleep aspects in liver cirrhosis: A case control study. World J Gastroenterol 2013; 19(22): 3433-3438 [PMID: 23801835 DOI: 10.3748/wjg.v19.i22.3433] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
146 Liu A, Yoo ER, Siddique O, Perumpail RB, Cholankeril G, Ahmed A. Hepatic encephalopathy: what the multidisciplinary team can do. J Multidiscip Healthc. 2017;10:113-119. [PMID: 28392702 DOI: 10.2147/jmdh.s118963] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
147 Bao ZJ, Qiu DK, Ma X, Fan ZP, Zhang GS, Huang YQ, Yu XF, Zeng MD. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007; 13(21): 3003-3008 [PMID: 17589955 DOI: 10.3748/wjg.v13.i21.3003] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
148 Ponziani FR, Funaro B, Lupascu A, Ainora ME, Garcovich M, Caracciolo G, Quadarella A, Nesci A, Riccardi L, Gasbarrini A, Pompili M, Zocco MA. Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study. Sci Rep 2019;9:15373. [PMID: 31653939 DOI: 10.1038/s41598-019-51867-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Urios A, Mangas-losada A, Gimenez-garzó C, González-lópez O, Giner-durán R, Serra MA, Noe E, Felipo V, Montoliu C. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits. Liver Int 2017;37:1013-22. [DOI: 10.1111/liv.13345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
150 Bajaj JS, Gillevet PM, Patel NR, Ahluwalia V, Ridlon JM, Kettenmann B, Schubert CM, Sikaroodi M, Heuman DM, Crossey MM. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab Brain Dis. 2012;27:205-215. [PMID: 22527995 DOI: 10.1007/s11011-012-9303-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
151 Qi R, Zhang LJ, Xu Q, Zhong J, Wu S, Zhang Z, Liao W, Ni L, Zhang Z, Chen H, Zhong Y, Jiao Q, Wu X, Fan X, Liu Y, Lu G. Selective impairments of resting-state networks in minimal hepatic encephalopathy.PLoS One. 2012;7:e37400. [PMID: 22662152 DOI: 10.1371/journal.pone.0037400] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
152 Schiano TD. Clinical Management of Hepatic Encephalopathy. Pharmacotherapy 2010;30:10S-5S. [DOI: 10.1592/phco.30.pt2.10s] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
153 Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ. Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis 2008;27:11-7. [PMID: 18681187 DOI: 10.1300/J069v27n02_02] [Cited by in Crossref: 65] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
154 Bamji N, Cohen LB. Endoscopic sedation of patients with chronic liver disease. Clin Liver Dis. 2010;14:185-194. [PMID: 20682228 DOI: 10.1016/j.cld.2010.03.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
155 Krismer F, Roos JC, Schranz M, Graziadei IW, Mechtcheriakov S, Vogel W, Carpenter RH, Zoller H. Saccadic latency in hepatic encephalopathy: a pilot study. Metab Brain Dis 2010;25:285-95. [PMID: 20852922 DOI: 10.1007/s11011-010-9210-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
156 Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol. 2011;46:750-759. [PMID: 21443422 DOI: 10.3109/00365521.2011.565067] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
157 Tartaglione EV, Derleth M, Yu L, Ioannou GN. Can computerized brain training games be used to identify early cognitive impairment in cirrhosis? Am J Gastroenterol 2014;109:316-23. [PMID: 24594947 DOI: 10.1038/ajg.2013.306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
158 Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, Takeda K, Kaito M, Takei Y. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol. 2008;103:1413-1420. [PMID: 18510613 DOI: 10.1111/j.1572-0241.2008.01788.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
159 Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, Angeli P, Gatta A. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol. 2008;49:346-353. [PMID: 18602716 DOI: 10.1016/j.jhep.2008.04.022] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 9.0] [Reference Citation Analysis]
160 Bristow P, Lipscomb V, Kummeling A, Packer R, Gerrits H, Homan K, Ortiz V, Newson K, Tivers M. Health-related quality of life following surgical attenuation of congenital portosystemic shunts versus healthy controls. J Small Anim Pract 2019;60:21-6. [PMID: 30251431 DOI: 10.1111/jsap.12927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
161 Mechtcheriakov S, Graziadei IW, Kugener A, Wiedemann J, Galbavy C, Hinterhuber H, Marksteiner J, Vogel W. Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: A clinical rating scale. World J Gastroenterol 2005; 11(37): 5893-5898 [PMID: 16270405 DOI: 10.3748/wjg.v11.i37.5893] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
162 Krishnarao A, Gordon FD. Prognosis of Hepatic Encephalopathy. Clin Liver Dis 2020;24:219-29. [PMID: 32245529 DOI: 10.1016/j.cld.2020.01.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Grønkjær LL, Andersen NG, Hansen LB, Sehstedt TH, Svensson NT, Sømod IE, Norlyk A, Bager P. Different views on hepatic encephalopathy: patients, relatives and nurses. Gastrointestinal Nursing 2016;14:S24-31. [DOI: 10.12968/gasn.2016.14.sup10.s24] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
164 Mullen KD, Prakash RK. Management of covert hepatic encephalopathy. Clin Liver Dis. 2012;16:91-93. [PMID: 22321467 DOI: 10.1016/j.cld.2012.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
165 Montagnese S, Middleton B, Skene DJ, Morgan MY. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. Liver International 2009;29:1372-82. [DOI: 10.1111/j.1478-3231.2009.02089.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
166 Unal G, de Boer JB, Borsboom GJ, Brouwer JT, Essink-Bot M, de Man RA. A psychometric comparison of health-related quality of life measures in chronic liver disease. J Clin Epidemiol 2001;54:587-96. [PMID: 11377119 DOI: 10.1016/s0895-4356(00)00372-3] [Cited by in Crossref: 73] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
167 Yazgan Y, Narin Y, Demirturk L, Saracoglu M, Ercan M, Akyatan N, Dalkanat N, Ozel AM, Cetin M. Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. J Gastroenterol Hepatol 2003;18:1162-7. [PMID: 12974903 DOI: 10.1046/j.1440-1746.2003.03141.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
168 Thompson JR. Treatment guidelines for hepatic encephalopathy. Pharmacotherapy. 2010;30:4S-9S. [PMID: 20412034 DOI: 10.1592/phco.30.pt2.4S] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
169 Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001;120:170-8. [DOI: 10.1053/gast.2001.21193] [Cited by in Crossref: 316] [Cited by in F6Publishing: 296] [Article Influence: 15.0] [Reference Citation Analysis]
170 Grover VP, Tognarelli JM, Massie N, Crossey MM, Cook NA, Taylor-Robinson SD. The why and wherefore of hepatic encephalopathy. Int J Gen Med 2015;8:381-90. [PMID: 26719720 DOI: 10.2147/IJGM.S86854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
171 Chen HJ, Wang Y, Zhu XQ, Cui Y, Chen YC, Teng GJ. White matter abnormalities correlate with neurocognitive performance in patients with HBV-related cirrhosis. J Neurol Sci. 2012;321:65-72. [PMID: 22877508 DOI: 10.1016/j.jns.2012.07.056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
172 Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol. 2006;101:1490-1496. [PMID: 16863551 DOI: 10.1111/j.1572-0241.2006.00649.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
173 Méndez M, Méndez-López M, López L, Aller MA, Arias J, Arias JL. Basal and learning task-related brain oxidative metabolism in cirrhotic rats. Brain Res Bull 2009;78:195-201. [PMID: 19015011 DOI: 10.1016/j.brainresbull.2008.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
174 Guest JF, Nanuwa K, Barden R. Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom. Health Qual Life Outcomes 2014;12:89. [PMID: 24917331 DOI: 10.1186/1477-7525-12-89] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
175 Citro V, Milan G, Tripodi FS, Gennari A, Sorrentino P, Gallotta G, Postiglione A, Tarantino G. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. J Gastroenterol 2007;42:79-82. [PMID: 17322997 DOI: 10.1007/s00535-006-1978-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
176 Prakash RK, Mullen KD. Is poor quality of life always present with minimal hepatic encephalopathy? Liver Int 2011;31:908-10. [PMID: 21733080 DOI: 10.1111/j.1478-3231.2011.02532.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
177 Bajaj JS, Thacker LR, Heuman DM, Gibson DP, Sterling RK, Stravitz RT, Fuchs M, Sanyal AJ, Wade JB. Driving simulation can improve insight into impaired driving skills in cirrhosis. Dig Dis Sci 2012;57:554-60. [PMID: 21901255 DOI: 10.1007/s10620-011-1888-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
178 Montagnese S, Amato E, Schiff S, Facchini S, Angeli P, Gatta A, Amodio P. A patients’ and caregivers’ perspective on hepatic encephalopathy. Metab Brain Dis 2012;27:567-72. [DOI: 10.1007/s11011-012-9325-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
179 Jiao Y, Wang XH, Chen R, Tang TY, Zhu XQ, Teng GJ. Predictive models of minimal hepatic encephalopathy for cirrhotic patients based on large-scale brain intrinsic connectivity networks. Sci Rep 2017;7:11512. [PMID: 28912425 DOI: 10.1038/s41598-017-11196-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
180 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998: Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gast. Hepatology 2002;35:716-21. [DOI: 10.1053/jhep.2002.31250] [Cited by in Crossref: 1381] [Cited by in F6Publishing: 1195] [Article Influence: 72.7] [Reference Citation Analysis]
181 Barone M, Shahini E, Iannone A, Viggiani MT, Corvace V, Principi M, Di Leo A. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Digestive and Liver Disease 2018;50:496-500. [DOI: 10.1016/j.dld.2018.01.133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
182 Flamm SL. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy. Am J Med Sci. 2018;356:296-303. [PMID: 30286824 DOI: 10.1016/j.amjms.2018.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
183 Douglass A, Al Mardini H, Record C. Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy. J Hepatol. 2001;34:658-664. [PMID: 11434611 DOI: 10.1016/s0168-8278(01)00004-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
184 Varakanahalli S, Sharma BC, Srivastava S, Sachdeva S, Dahale AS. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo. Eur J Gastroenterol Hepatol 2018;30:951-8. [PMID: 29727385 DOI: 10.1097/MEG.0000000000001137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
185 Nakanishi H, Kurosaki M, Nakanishi K, Tsuchiya K, Noda T, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Itakura J, Anami K, Asahina Y, Enomoto N, Higuchi T, Izumi N. Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy. Hepatol Res 2014;44:319-26. [PMID: 23607661 DOI: 10.1111/hepr.12127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
186 Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications. Neurochem Int 2009;55:106-12. [PMID: 19428813 DOI: 10.1016/j.neuint.2009.01.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
187 Wunsch E, Naprawa G, Koziarska D, Milkiewicz M, Nowacki P, Milkiewicz P. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study. Annals of Hepatology 2013;12:448-55. [DOI: 10.1016/s1665-2681(19)31008-7] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
188 Dhiman RK. Impact of minimal/covert hepatic encephalopathy on patients with cirrhosis. Clin Liver Dis (Hoboken) 2015;5:75-8. [PMID: 31040955 DOI: 10.1002/cld.452] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
189 Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003;96:623-633. [PMID: 12925717 DOI: 10.1093/qjmed/hcg110] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
190 Solga S. Probiotics can treat hepatic encephalopathy. Medical Hypotheses 2003;61:307-13. [DOI: 10.1016/s0306-9877(03)00192-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
191 Velissaris D, Karanikolas M, Kalogeropoulos A, Solomou E, Polychronopoulos P, Thomopoulos K, Labropoulou-Karatza C. Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy. World J Gastroenterol 2008; 14(26): 4190-4195 [PMID: 18636665 DOI: 10.3748/wjg.14.4190] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
192 Schliess F, Görg B, Häussinger D. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm. Biol Chem. 2006;387:1363-1370. [PMID: 17081108 DOI: 10.1515/bc.2006.171] [Cited by in Crossref: 58] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
193 Sharma P, Sharma BC. Disaccharides in the treatment of hepatic encephalopathy. Metab Brain Dis 2013;28:313-20. [PMID: 23456517 DOI: 10.1007/s11011-013-9392-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
194 Sharma P, Sharma BC, Puri V, Sarin SK. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2009;104:885-90. [PMID: 19293781 DOI: 10.1038/ajg.2009.84] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
195 Michitaka K, Tokumoto Y, Uesugi K, Kisaka Y, Hirooka M, Konishi I, Mashiba T, Abe M, Hiasa Y, Matsuura B, Horiike N, Shoda T, Onji M. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research 2008;38:1069-75. [DOI: 10.1111/j.1872-034x.2008.00374.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
196 Bajaj JS, Thacker LR, Heuman DM, Sterling RK, Stravitz RT, Sanyal AJ, Luketic V, Fuchs M, Gilles HC, Wade JB. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study. Liver Transpl. 2012;18:1179-1187. [PMID: 22674517 DOI: 10.1002/lt.23484] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
197 Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H. Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis 2012;27:559-65. [DOI: 10.1007/s11011-012-9318-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
198 Ciećko-Michalska I, Wójcik J, Senderecka M, Wyczesany M, Binder M, Szewczyk J, Dziedzic T, Słowik A, Mach T. Cognitive functions in patients with liver cirrhosis: a tendency to commit more memory errors. Med Sci Monit 2013;19:283-8. [PMID: 23598598 DOI: 10.12659/MSM.883890] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
199 Romero Gómez M, Córdoba J, Jover R, del Olmo J, Fernández A, Flavià M, Compañy L, Poveda MJ, Felipo V; Red Nacional de Investigación en Encefalopatía Hepática. [Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy]. Med Clin (Barc) 2006;127:246-9. [PMID: 16942726 DOI: 10.1157/13091264] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
200 Suzuki H, Sezaki H, Suzuki F, Kasuya K, Sano T, Fujiyama S, Kawamura Y, Hosaka T, Akuta N, Saitoh S, Kobayashi M, Arase Y, Ikeda K, Suzuki Y, Kumada H. Real‐world effects of long‐term rifaximin treatment for Japanese patients with hepatic encephalopathy. Hepatol Res 2019;49:1406-13. [DOI: 10.1111/hepr.13415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
201 Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2008;20:506-511. [PMID: 18467909 DOI: 10.1097/meg.0b013e3282f3e6f5] [Cited by in Crossref: 120] [Cited by in F6Publishing: 37] [Article Influence: 9.2] [Reference Citation Analysis]
202 Torlot FJ, McPhail MJ, Taylor-Robinson SD. Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy. Aliment Pharmacol Ther. 2013;37:527-536. [PMID: 23293917 DOI: 10.1111/apt.12199] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
203 Cunniffe N, Munby H, Chan S, Saatci D, Edison E, Carpenter RHS, Massey D. Using saccades to diagnose covert hepatic encephalopathy. Metab Brain Dis 2015;30:821-8. [DOI: 10.1007/s11011-014-9647-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
204 Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int. 2018;38:399-411. [PMID: 28921801 DOI: 10.1111/liv.13591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
205 Mínguez B, García-Pagán JC, Bosch J, Turnes J, Alonso J, Rovira A, Córdoba J. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006;43:707-14. [PMID: 16557541 DOI: 10.1002/hep.21126] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 5.1] [Reference Citation Analysis]
206 Campagna F, Biancardi A, Cillo U, Gatta A, Amodio P. Neurocognitive-neurological complications of liver transplantation: a review. Metab Brain Dis. 2010;25:115-124. [PMID: 20204483 DOI: 10.1007/s11011-010-9183-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
207 Zhou Y, Chen S, Jiang L, Guo C, Shen Z, Huang P, Wang J. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2009;24:408-15. [DOI: 10.1111/j.1440-1746.2008.05678.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
208 Montagnese S, Bajaj JS. Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues. Drugs 2019;79:11-6. [PMID: 30706419 DOI: 10.1007/s40265-018-1019-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
209 McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev. 2011;CD008716. [PMID: 22071855 DOI: 10.1002/14651858.cd008716.pub2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
210 Aceto P, Perilli V, Lai C, Ciocchetti P, Vitale F, Sollazzi L. Postoperative cognitive dysfunction after liver transplantation. General Hospital Psychiatry 2015;37:109-15. [DOI: 10.1016/j.genhosppsych.2014.12.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
211 Metwally MA, Biomy HA, Omar MZ, Sakr AI. Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2019;31:1030-1034. [PMID: 31274595 DOI: 10.1097/meg.0000000000001375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
212 Weissenborn K. Minimal hepatic encephalopathy: a permanent source of discussion. Hepatology. 2002;35:494-496. [PMID: 11826427 DOI: 10.1053/jhep.2002.31552] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
213 Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ; Korean Association for the Study of the Liver. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18:1-21. [PMID: 22511898 DOI: 10.3350/kjhep.2012.18.1.1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 9.4] [Reference Citation Analysis]
214 Patidar KR, Bajaj JS. Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. Clin Gastroenterol Hepatol 2015;13:2048-61. [PMID: 26164219 DOI: 10.1016/j.cgh.2015.06.039] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
215 Quero Guillén JC, Herrerías Gutiérrez JM. Diagnostic methods in hepatic encephalopathy. Clin Chim Acta 2006;365:1-8. [PMID: 16168979 DOI: 10.1016/j.cca.2005.08.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
216 Singh R, Sharma PK, Malviya R. Prebiotics: future trends in health care. Mediterr J Nutr Metab 2012;5:81-90. [DOI: 10.1007/s12349-011-0065-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Li T, Li X, Zhou W, Cui X, Ma L. Dynamic susceptibility contrast-enhanced first-pass perfusion MR imaging in patients with subclinical hepatic encephalopathy. J Neuroradiol. 2012;39:290-294. [PMID: 22047891 DOI: 10.1016/j.neurad.2011.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
218 Moon J, Jun DW, Yum M, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS, Hahm JS, Seol IJ, Oh J, Kim C. Prolonged N200 is the early neurophysiologic change in the patient with minimal hepatic encephalopathy. Scandinavian Journal of Gastroenterology 2014;49:604-10. [DOI: 10.3109/00365521.2013.878382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
219 Seo YS, Yim SY, Jung JY, Kim CH, Kim JD, Keum B, An H, Yim HJ, Lee HS, Kim CD, Ryu HS, Um SH. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterol Hepatol. 2012;27:1695-1704. [PMID: 22743001 DOI: 10.1111/j.1440-1746.2012.07217.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
220 Yoo HY, Edwin D, Thuluvath PJ. Relationship of The Model for End-Stage Liver Disease (Meld) Scale To Hepatic Encephalopathy, As Defined by Electroencephalography and Neuropsychometric Testing, and Ascites. American Journal of Gastroenterology 2003;98:1395-9. [DOI: 10.1111/j.1572-0241.2003.07466.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
221 Ong JP, Oehler G, Krüger-jansen C, Lambert-baumann J, Younossi ZM. Oral L-Ornithine-L-Aspartate Improves Health-Related Quality of Life in Cirrhotic Patients with Hepatic Encephalopathy: An Open-Label, Prospective, Multicentre Observational Study. Clinical Drug Investigation 2011;31:213-20. [DOI: 10.2165/11586700-000000000-00000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
222 Ennaifer R, Cheikh M, Hefaiedh R, Romdhane H, Ben Nejma H, Hadj NB. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic]. Presse Med 2014;43:e127-33. [PMID: 24703736 DOI: 10.1016/j.lpm.2013.09.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
223 Zullo A, Rinaldi V, Meddi P, Hassan C, Winn S, Attili AF. Helicobacter Pylori Infection, Plasma Ammonia Levels, and Psychometric Testing in Cirrhotic Patients. American Journal of Gastroenterology 1999;94:2214-8. [DOI: 10.1111/j.1572-0241.1999.01295.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
224 Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, Hasebe A, Miyamoto Y, Ichiryu M, Tanihira T. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res. 2010;40:393-398. [PMID: 20236360 DOI: 10.1111/j.1872-034x.2009.00614.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
225 Montagnese S, Schiff S, De Rui M, Crossey MM, Amodio P, Taylor-Robinson SD. Neuropsychological tools in hepatology: a survival guide for the clinician. J Viral Hepat. 2012;19:307-315. [PMID: 22497809 DOI: 10.1111/j.1365-2893.2012.01592.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
226 Kato A, Tanaka H, Kawaguchi T, Kanazawa H, Iwasa M, Sakaida I, Moriwaki H, Murawaki Y, Suzuki K, Okita K. Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open-label study. Hepatol Res. 2013;43:452-458. [PMID: 22994429 DOI: 10.1111/j.1872-034x.2012.01092.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
227 Zhao X, Wong P. Managing Sleep Disturbances in Cirrhosis. Scientifica (Cairo) 2016;2016:6576812. [PMID: 27242950 DOI: 10.1155/2016/6576812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
228 Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol. 2007;102:1903-1909. [PMID: 17640323 DOI: 10.1111/j.1572-0241.2007.01424.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 102] [Article Influence: 8.1] [Reference Citation Analysis]
229 Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK. Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver: Minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2010;25:1029-41. [DOI: 10.1111/j.1440-1746.2010.06318.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
230 Felipo V. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy. World J Gastroenterol 2006; 12(48): 7737-7743 [PMID: 17203513 DOI: 10.3748/wjg.v12.i48.7737] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
231 Cauli O, Mlili N, Llansola M, Felipo V. Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats. Eur J Neurosci 2007;25:2112-22. [PMID: 17439495 DOI: 10.1111/j.1460-9568.2007.05435.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
232 Gupta D, Ingle M, Shah K, Phadke A, Sawant P. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent. J Dig Dis. 2015;16:400-407. [PMID: 25858627 DOI: 10.1111/1751-2980.12248] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
233 Zhang D, Tu L, Zhang LJ, Jie B, Lu GM. Subnetwork mining on functional connectivity network for classification of minimal hepatic encephalopathy. Brain Imaging Behav 2018;12:901-11. [PMID: 28717971 DOI: 10.1007/s11682-017-9753-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
234 Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol. 2011;106:307-316. [PMID: 21157444 DOI: 10.1038/ajg.2010.455] [Cited by in Crossref: 155] [Cited by in F6Publishing: 138] [Article Influence: 12.9] [Reference Citation Analysis]
235 Telles-correia D, João Freire M, Mega I, Barreiras D, Cortez Pinto H. Anxiety and Depression Symptoms in Hepatic Encephalopathy: Are They Psychiatric or Organic? Transplantation Proceedings 2015;47:1005-7. [DOI: 10.1016/j.transproceed.2015.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
236 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;4:CD003044. [PMID: 27089005 DOI: 10.1002/14651858.cd003044.pub3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
237 Henderson PK, Herrera JL. Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What? Clin Liver Dis 2015;19:487-95. [PMID: 26195203 DOI: 10.1016/j.cld.2015.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
238 Montoliu C, Cauli O, Urios A, ElMlili N, Serra MA, Giner-Duran R, González-Lopez O, Del Olmo JA, Wassel A, Rodrigo JM. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol. 2011;106:1629-1637. [PMID: 21483460 DOI: 10.1038/ajg.2011.123] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
239 Subasinghe SK, Nandamuni Y, Ranasinghe S, Niriella MA, Miththinda JK, Dassanayake A, de Silva AP, de Silva HJ. Association between road accidents and low-grade hepatic encephalopathy among Sri Lankan drivers with cirrhosis: a prospective case control study. BMC Res Notes 2016;9:303. [PMID: 27296988 DOI: 10.1186/s13104-016-2106-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
240 Kato A, Watanabe Y, Sawara K, Suzuki K. Diagnosis of sub-clinical hepatic encephalopathy by Neuropsychological Tests (NP-tests). Hepatology Research 2008;38:S122-7. [DOI: 10.1111/j.1872-034x.2008.00437.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
241 Méndez M, Méndez-López M, López L, Aller MA, Arias J, Arias JL. Working memory impairment and reduced hippocampal and prefrontal cortex c-Fos expression in a rat model of cirrhosis. Physiol Behav 2008;95:302-7. [PMID: 18634813 DOI: 10.1016/j.physbeh.2008.06.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
242 Bajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, Hischke D, Hammeke TA, Pinkerton SD, Saeian K. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135:1591-1600.e1. [PMID: 18723018 DOI: 10.1053/j.gastro.2008.07.021] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 10.6] [Reference Citation Analysis]
243 Bianchi G, Giovagnoli M, Sasdelli AS, Marchesini G. Hepatic encephalopathy and health-related quality of life. Clin Liver Dis 2012;16:159-70. [PMID: 22321471 DOI: 10.1016/j.cld.2011.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
244 Samanta J, Dhiman RK, Khatri A, Thumburu KK, Grover S, Duseja A, Chawla Y. Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. Metab Brain Dis 2013;28:249-59. [DOI: 10.1007/s11011-013-9393-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
245 Sharma K, Pant S, Misra S, Dwivedi M, Misra A, Narang S, Tewari R, Bhadoria AS. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial. Saudi J Gastroenterol. 2014;20:225-232. [PMID: 25038208 DOI: 10.4103/1319-3767.136975] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
246 Sharma P, Kumar A. Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient. Saudi J Gastroenterol 2012;18:316-21. [PMID: 23006459 DOI: 10.4103/1319-3767.101126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
247 Adrover R, Cocozzella D, Ridruejo E, García A, Rome J, Podestá JJ. Breath-ammonia testing of healthy subjects and patients with cirrhosis. Dig Dis Sci. 2012;57:189-195. [PMID: 21842240 DOI: 10.1007/s10620-011-1858-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
248 Ferenci P. Diagnosis of minimal hepatic encephalopathy: still a challenge. Gut 2013;62:1394-1394. [DOI: 10.1136/gutjnl-2012-304270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
249 Flamm SL. Covert Hepatic Encephalopathy: Who Should Be Tested and Treated? Clin Liver Dis 2015;19:473-85. [PMID: 26195202 DOI: 10.1016/j.cld.2015.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
250 Gairing SJ, Anders J, Kaps L, Nagel M, Michel M, Kremer WM, Hilscher M, Galle PR, Schattenberg JM, Wörns MA, Labenz C. Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatol Commun 2022. [PMID: 35032100 DOI: 10.1002/hep4.1883] [Reference Citation Analysis]
251 Agrawal S, Umapathy S, Dhiman RK. Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol. 2015;5:S42-S48. [PMID: 26041957 DOI: 10.1016/j.jceh.2014.11.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
252 Lauridsen MM, Jepsen P, Vilstrup H. Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis. 2011;26:135-139. [PMID: 21484318 DOI: 10.1007/s11011-011-9242-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
253 Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial. Clin Gastroenterol Hepatol 2016; 14: 454-460. quiz e33. [PMID: 26453952 DOI: 10.1016/j.cgh.2015.09.028] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
254 May ES, Butz M, Kahlbrock N, Brenner M, Hoogenboom N, Kircheis G, Häussinger D, Schnitzler A. Hepatic encephalopathy is associated with slowed and delayed stimulus-associated somatosensory alpha activity. Clinical Neurophysiology 2014;125:2427-35. [DOI: 10.1016/j.clinph.2014.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
255 Meyer T, Eshelman A, Abouljoud M. Neuropsychological Changes in a Large Sample of Liver Transplant Candidates. Transplantation Proceedings 2006;38:3559-60. [DOI: 10.1016/j.transproceed.2006.10.050] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
256 Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007;25 Suppl 1:3-9. [PMID: 17295846 DOI: 10.1111/j.1746-6342.2006.03215.x] [Cited by in Crossref: 238] [Cited by in F6Publishing: 200] [Article Influence: 15.9] [Reference Citation Analysis]
257 Teperman LW. Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes. Int J Hepatol 2013;2013:952828. [PMID: 24324895 DOI: 10.1155/2013/952828] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
258 Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. [PMID: 26041963 DOI: 10.1016/j.jceh.2014.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
259 Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology. 2010;139:510-518, 518.e1-518.e2. [PMID: 20470775 DOI: 10.1053/j.gastro.2010.04.057] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
260 Sharma P, Sharma BC, Tyagi P, Kumar M, Sarin SK. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy. Liver Int 2009;29:260-4. [PMID: 18710429 DOI: 10.1111/j.1478-3231.2008.01856.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
261 Montagnese S, Amodio P, Morgan MY. Methods for Diagnosing Hepatic Encephalopathy in Patients with Cirrhosis: A Multidimensional Approach. Metab Brain Dis 2004;19:281-312. [DOI: 10.1023/b:mebr.0000043977.11113.2a] [Cited by in Crossref: 83] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
262 Valcour VG, Rubin LH, Obasi MU, Maki PM, Peters MG, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC; Womenʼs Interagency HIV Study Protocol Team. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C. J Acquir Immune Defic Syndr 2016;72:266-73. [PMID: 26885801 DOI: 10.1097/QAI.0000000000000957] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
263 Kircheis G, Görtelmeyer R, Fleig WE, Häussinger D. Critical assessment of the PHES test battery in patients with low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 495-502. [DOI: 10.1007/1-4020-4456-9_39] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
264 Bale A, Pai CG, Shetty S, Balaraju G, Shetty A. Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver. J Clin Exp Hepatol 2018;8:156-61. [PMID: 29892178 DOI: 10.1016/j.jceh.2017.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
265 Sharma P, Sharma BC, Puri V, Sarin SK. Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction. Am J Gastroenterology 2008;103:1406-12. [DOI: 10.1111/j.1572-0241.2008.01830.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
266 Nardone R, Taylor AC, Höller Y, Brigo F, Lochner P, Trinka E. Minimal hepatic encephalopathy: A review. Neurosci Res 2016;111:1-12. [PMID: 27153746 DOI: 10.1016/j.neures.2016.04.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
267 Edwin D, Flynn L, Klein A, Thuluvath PJ. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients. Hepatology. 1999;30:1363-1367. [PMID: 10573512 DOI: 10.1002/hep.510300605] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
268 Jiménez B, Montoliu C, MacIntyre DA, Serra MA, Wassel A, Jover M, Romero-Gomez M, Rodrigo JM, Pineda-Lucena A, Felipo V. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance. J Proteome Res. 2010;9:5180-5187. [PMID: 20690770 DOI: 10.1021/pr100486e] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
269 Pratap Mouli V, Benjamin J, Bhushan Singh M, Mani K, Garg SK, Saraya A, Joshi YK. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. Hepatol Res. 2015;45:880-889. [PMID: 25266207 DOI: 10.1111/hepr.12429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
270 Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology. 2007;45:833-834. [PMID: 17326210 DOI: 10.1002/hep.21515] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 7.1] [Reference Citation Analysis]
271 Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. Journal of Hepatology 2001;35:37-45. [DOI: 10.1016/s0168-8278(01)00129-5] [Cited by in Crossref: 167] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
272 Qi R, Zhang LJ, Xu Q, Liang X, Luo S, Zhang Z, Huang W, Zheng L, Lu GM. Abnormal functional connectivity within the default mode network in patients with HBV-related cirrhosis without hepatic encephalopathy revealed by resting-state functional MRI. Brain Res 2014;1576:73-80. [PMID: 24907446 DOI: 10.1016/j.brainres.2014.05.044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
273 Amodio P, Gatta A. Neurophysiological Investigation of Hepatic Encephalopathy. Metab Brain Dis 2005;20:369-79. [DOI: 10.1007/s11011-005-7921-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
274 Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010;7:515-25. [DOI: 10.1038/nrgastro.2010.116] [Cited by in Crossref: 174] [Cited by in F6Publishing: 152] [Article Influence: 14.5] [Reference Citation Analysis]
275 Burkard T, Biedermann A, Herold C, Dietlein M, Rauch M, Diefenbach M. Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Eur J Gastroenterol Hepatol. 2013;25:352-358. [PMID: 23117470 DOI: 10.1097/MEG.0b013e32835afaa5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
276 Montagnese S, De Rui M, Angeli P, Amodio P. Neuropsychiatric performance in patients with cirrhosis: Who is "normal"? J Hepatol 2017;66:825-35. [PMID: 27923694 DOI: 10.1016/j.jhep.2016.11.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
277 Qi R, Zhang LJ, Zhong J, Zhang Z, Ni L, Jiao Q, Liao W, Zheng G, Lu G. Altered effective connectivity network of the basal ganglia in low-grade hepatic encephalopathy: a resting-state fMRI study with Granger causality analysis. PLoS One. 2013;8:e53677. [PMID: 23326484 DOI: 10.1371/journal.pone.0053677] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
278 Scotiniotis IA, Lucey MR, Metz DC. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig Dis Sci. 2001;46:2744-2751. [PMID: 11768268 DOI: 10.1023/a:1012787731821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
279 Özbaş B, Keskin O, Hecker H, Karahan I, Özbaş C, Kalkan Ç, Kartal A, Önder FO, Öncü BK, Gençdal G, Akyildiz M, Günşar F, Idilman R, Weissenborn K, Özütemiz Ö, Yurdaydin C. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery. Hepatol Int 2021. [PMID: 34085147 DOI: 10.1007/s12072-021-10207-5] [Reference Citation Analysis]
280 Chen HJ, Chen R, Yang M, Teng GJ, Herskovits EH. Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining. AJNR Am J Neuroradiol 2015;36:481-7. [PMID: 25500314 DOI: 10.3174/ajnr.A4146] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
281 Taneja S, Dhiman RK, Khatri A, Goyal S, Thumbru KK, Agarwal R, Duseja A, Chawla Y. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver. J Clin Exp Hepatol. 2012;2:306-314. [PMID: 25755452 DOI: 10.1016/j.jceh.2012.07.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
282 Ding S, Wang W, Wang X, Liang Y, Liu L, Ye Y, Yang J, Gao H, Zhuge Q. Dopamine Burden Triggers Neurodegeneration via Production and Release of TNF-α from Astrocytes in Minimal Hepatic Encephalopathy. Mol Neurobiol 2016;53:5324-43. [PMID: 26433377 DOI: 10.1007/s12035-015-9445-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
283 Felipo V, Ordoño JF, Urios A, El Mlili N, Giménez-Garzó C, Aguado C, González-Lopez O, Giner-Duran R, Serra MA, Wassel A, Rodrigo JM, Salazar J, Montoliu C. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology 2012;55:530-9. [PMID: 21953369 DOI: 10.1002/hep.24704] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
284 Mardini HA, Douglass A, Record C. Amino Acid Challenge in Patients with Cirrhosis and Control Subjects: Ammonia, Plasma Amino Acid and EEG Changes. Metab Brain Dis 2006;21:1-10. [DOI: 10.1007/s11011-006-9006-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
285 Amodio P, Caregaro L, Pattenò E, Marcon M, Del Piccolo F, Gatta A. Vegetarian diets in hepatic encephalopathy: facts or fantasies? Dig Liver Dis 2001;33:492-500. [PMID: 11572577 DOI: 10.1016/s1590-8658(01)80028-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
286 Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. Journal of Hepatology 2005;42:S45-53. [DOI: 10.1016/j.jhep.2004.11.028] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 10.5] [Reference Citation Analysis]
287 Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease. Am J Gastroenterol. 2004;99:1726-1732. [PMID: 15330910 DOI: 10.1111/j.1572-0241.2004.30300.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
288 Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24-36. [PMID: 30345878 DOI: 10.1177/0269216318807051] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 12.3] [Reference Citation Analysis]
289 Mina A, Moran S, Ortiz-Olvera N, Mera R, Uribe M. Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis. Hepatol Res. 2014;44:E92-E99. [PMID: 24033755 DOI: 10.1111/hepr.12227] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
290 Goel A, Yadav S, Saraswat V, Srivastava A, Thomas MA, Pandey CM, Rathore R, Gupta R. Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction: Cerebral oedema in extrahepatic portal venous obstruction. Liver International 2010;30:1143-51. [DOI: 10.1111/j.1478-3231.2010.02289.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
291 Bajaj JS, Thacker LR, Wade JB, Sanyal AJ, Heuman DM, Sterling RK, Gibson DP, Stravitz RT, Puri P, Fuchs M. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther. 2011;34:1123-1132. [PMID: 21929591 DOI: 10.1111/j.1365-2036.2011.04842.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
292 Amorós A, Aparicio JR, Garmendia M, Casellas JA, Martínez J, Jover R. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Gastrointest Endosc. 2009;70:262-268. [PMID: 19394004 DOI: 10.1016/j.gie.2008.10.038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
293 Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver Int. 2010;30:574-582. [PMID: 20456040 DOI: 10.1111/j.1478-3231.2010.02213.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
294 Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
295 Mullen K, Prakash R. Rifaximin for the treatment of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 2010;4:665-77. [PMID: 21108586 DOI: 10.1586/egh.10.78] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
296 Ciancio A, Marchet A, Saracco G, Carucci P, Lavezzo B, Leotta D, Capellero B, Nobili M, Smedile A, Rizzetto M. Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation. Liver Transpl 2002;8:630-5. [PMID: 12089718 DOI: 10.1053/jlts.2002.33971] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
297 Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, Häussinger D. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009;137:1706-15.e1-9. [PMID: 19686744 DOI: 10.1053/j.gastro.2009.08.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
298 Acharya C, Bajaj JS. Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access. Liver Transpl 2021. [PMID: 34018659 DOI: 10.1002/lt.26099] [Reference Citation Analysis]
299 Thuluvath PJ, Nuthalapati A, Price J, Maheshwari A. Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments. J Clin Exp Hepatol 2016;6:3-9. [PMID: 27194889 DOI: 10.1016/j.jceh.2015.09.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
300 Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol. 2009;43:272-279. [PMID: 18562979 DOI: 10.1097/mcg.0b013e31815e7f58] [Cited by in Crossref: 107] [Cited by in F6Publishing: 53] [Article Influence: 8.2] [Reference Citation Analysis]
301 Ziada DH, Soliman HH, El Yamany SA, Hamisa MF, Hasan AM. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? Arab J Gastroenterol. 2013;14:116-122. [PMID: 24206740 DOI: 10.1016/j.ajg.2013.08.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
302 Agusti A, Dziedzic JL, Hernandez-Rabaza V, Guilarte TR, Felipo V. Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition. Metab Brain Dis 2014;29:955-63. [PMID: 24307181 DOI: 10.1007/s11011-013-9461-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
303 Jesús Maldonado-garza H, Vázquez-elizondo G, Obed Gaytán-torres J, Ricardo Flores-rendón Á, Graciela Cárdenas-sandoval M, Javier Bosques-padilla F. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Annals of Hepatology 2011;10:S40-4. [DOI: 10.1016/s1665-2681(19)31605-9] [Cited by in Crossref: 19] [Article Influence: 1.7] [Reference Citation Analysis]
304 Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549-559. [PMID: 17326150 DOI: 10.1002/hep.21533] [Cited by in Crossref: 385] [Cited by in F6Publishing: 325] [Article Influence: 25.7] [Reference Citation Analysis]
305 Singh J, Sharma BC, Puri V, Sachdeva S, Srivastava S. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. Metab Brain Dis. 2017;32:595-605. [PMID: 28070704 DOI: 10.1007/s11011-016-9944-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
306 Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14(23): 3609-3615 [PMID: 18595126 DOI: 10.3748/wjg.14.3609] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
307 Ding S, Liu L, Jing H, Xie J, Wang X, Mao J, Chen B, Zhuge Q. Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy. Hepatol Int 2013;7:923-36. [PMID: 26201931 DOI: 10.1007/s12072-013-9431-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
308 Vaisman N, Katzman H, Carmiel-Haggai M, Lusthaus M, Niv E. Breakfast improves cognitive function in cirrhotic patients with cognitive impairment. Am J Clin Nutr. 2010;92:137-140. [PMID: 20444959 DOI: 10.3945/ajcn.2010.29211] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
309 Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. Journal of Hepatology 2007;46:447-58. [DOI: 10.1016/j.jhep.2006.10.015] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
310 Dalal R, McGee RG, Riordan SM, Webster AC. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;2:CD008716. [PMID: 28230908 DOI: 10.1002/14651858.cd008716.pub3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
311 Bongaerts G, Severijnen R, Timmerman H. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy. Med Hypotheses 2005;64:64-8. [PMID: 15533613 DOI: 10.1016/j.mehy.2004.07.029] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
312 Bajaj JS, Riggio O, Allampati S, Prakash R, Gioia S, Onori E, Piazza N, Noble NA, White MB, Mullen KD. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: An international multicenter study. Clin Gastroenterol Hepatol. 2013;11:1511-1516. [PMID: 23707462 DOI: 10.1016/j.cgh.2013.05.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
313 Qi R, Xu Q, Zhang LJ, Zhong J, Zheng G, Wu S, Zhang Z, Liao W, Zhong Y, Ni L. Structural and functional abnormalities of default mode network in minimal hepatic encephalopathy: a study combining DTI and fMRI. PLoS One. 2012;7:e41376. [PMID: 22911787 DOI: 10.1371/journal.pone.0041376] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
314 Córdoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011;54:1030-1040. [PMID: 21145874 DOI: 10.1016/j.jhep.2010.11.015] [Cited by in Crossref: 143] [Cited by in F6Publishing: 120] [Article Influence: 11.9] [Reference Citation Analysis]
315 Velissaris D, Karamouzos V, Polychronopoulos P, Karanikolas M. Chronotypology and melatonin alterations in minimal hepatic encephalopathy. J Circadian Rhythms 2009;7:6. [PMID: 19480668 DOI: 10.1186/1740-3391-7-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
316 Mattarozzi K, Campi C, Guarino M, Stracciari A. Distinguishing between clinical and minimal hepatic encephalopathy on the basis of specific cognitive impairment. Metab Brain Dis 2005;20:243-9. [PMID: 16167202 DOI: 10.1007/s11011-005-7212-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
317 Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Fuchs M, Luketic V, Sanyal AJ. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011;140:478-487.e1. [PMID: 20849805 DOI: 10.1053/j.gastro.2010.08.061] [Cited by in Crossref: 141] [Cited by in F6Publishing: 125] [Article Influence: 11.8] [Reference Citation Analysis]
318 Compañy L, Zapater P, Pérez-Mateo M, Jover R. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2010;22:519-25. [PMID: 20010298 DOI: 10.1097/MEG.0b013e328333df0f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
319 Eroglu Y, Byrne WJ. Hepatic encephalopathy. Emerg Med Clin North Am 2009;27:401-14. [PMID: 19646644 DOI: 10.1016/j.emc.2009.04.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
320 Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718-2723. [PMID: 11569701 DOI: 10.1111/j.1572-0241.2001.04130.x] [Cited by in Crossref: 233] [Cited by in F6Publishing: 221] [Article Influence: 11.1] [Reference Citation Analysis]
321 Gluud LL, Jeyaraj R, Morgan MY. Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy. J Clin Exp Hepatol 2019;9:354-61. [PMID: 31360028 DOI: 10.1016/j.jceh.2019.02.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
322 Erceg S, Monfort P, Cauli O, Montoliu C, Llansola M, Piedrafita B, Felipo V. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications. Neurochem Int 2006;48:441-6. [PMID: 16497413 DOI: 10.1016/j.neuint.2005.10.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
323 Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology 2007;45:547-8. [DOI: 10.1002/hep.21617] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
324 Ridola L, Nardelli S, Gioia S, Riggio O. Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol 2018; 24(48): 5446-5453 [PMID: 30622374 DOI: 10.3748/wjg.v24.i48.5446] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
325 Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K; International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:629-635. [PMID: 19302444 DOI: 10.1111/j.1478-3231.2009.02009.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 11.5] [Reference Citation Analysis]
326 Collie A. Cognition in liver disease. Liver Int 2005;25:1-8. [PMID: 15698392 DOI: 10.1111/j.1478-3231.2005.01012.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
327 Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2008;2:785-790. [PMID: 19090738 DOI: 10.1586/17474124.2.6.785] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
328 Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30:881-894. [PMID: 19678814 DOI: 10.1111/j.1365-2036.2009.04116.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 69] [Article Influence: 6.8] [Reference Citation Analysis]
329 Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of Minimal Hepatic Encephalopathy. Metab Brain Dis 2004;19:253-67. [DOI: 10.1023/b:mebr.0000043975.01841.de] [Cited by in Crossref: 196] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
330 Jackson CD, Gram M, Halliday E, Olesen SS, Sandberg TH, Drewes AM, Morgan MY. New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy. Clin Neurophysiol 2016;127:2933-41. [PMID: 27236607 DOI: 10.1016/j.clinph.2016.03.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
331 Khokhar N, Qureshi MO, Ahmad S, Ahmad A, Khan HH, Shafqat F, Salih M. Comparison of once a day rifaximin to twice a day dosage in the prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease. J Gastroenterol Hepatol 2015;30:1420-2. [PMID: 25867912 DOI: 10.1111/jgh.12970] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
332 Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis. 2001;16:37-41. [PMID: 11726087 DOI: 10.1023/a:1011610427843] [Cited by in Crossref: 142] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
333 Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres ML, Civera M, Olmo JA, Ortega J, Martinez-Valls J, Serra MA, Cassinello N, Wassel A, Jordá E, Montoliu C. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis 2012;27:51-8. [PMID: 22072427 DOI: 10.1007/s11011-011-9269-3] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 9.0] [Reference Citation Analysis]